1. Home
  2. IBIO

as of 02-17-2026 3:53pm EST

$2.28
$0.02
-0.66%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Founded: 2008 Country:
N/A
Employees: N/A City: NEW YORK
Market Cap: 50.4M IPO Year: N/A
Target Price: $4.00 AVG Volume (30 days): 1.0M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $0.56 - $6.89 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): -61.75% Revenue Growth (next year): 11.11%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered IBIO Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 15 hours ago

AI Recommendation

hold
Model Accuracy: 71.15%
71.15%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: